Anticoagulation Management for Lumbar Vertebral Fractures
For patients with lumbar vertebral fractures requiring VTE prophylaxis, initiate pharmacologic thromboprophylaxis at 72 hours post-operatively if surgical fixation was performed, or immediately if managed non-operatively, using standard prophylactic dosing of enoxaparin, fondaparinux, or low-dose unfractionated heparin. If aspirin is already being taken for cardiovascular indications, continue it during the acute fracture period.
Timing of Anticoagulation Initiation
The critical decision point is whether the fracture was surgically treated:
Post-Surgical Patients:
- Wait 72 hours after spinal fixation before initiating chemoprophylaxis 1
- This timing significantly reduces VTE events (from 30% to 4.4%) without increasing bleeding complications 1
- Earlier initiation (<72 hours) is associated with higher bleeding risk without additional VTE protection 1
Non-Surgical/Conservative Management:
- Begin prophylaxis immediately upon hospitalization if the patient is immobilized 2
- Use mechanical prophylaxis (intermittent pneumatic compression) if bleeding risk is high until pharmacologic agents can be safely started 2
Prophylactic Agent Selection
First-Line Options (choose one):
- Enoxaparin 40 mg subcutaneous once daily 2
- Fondaparinux 2.5 mg subcutaneous once daily 2
- Unfractionated heparin 5,000 units subcutaneous twice or three times daily 2
Apixaban is NOT recommended for VTE prophylaxis in this setting - it is only FDA-approved for prophylaxis after elective hip/knee arthroplasty, not trauma or spinal surgery 3. The evidence shows apixaban may actually increase thrombotic complications in orthopedic trauma compared to aspirin 4.
Duration of Prophylaxis
- Continue for 10-14 days minimum 2
- Consider extending to 35 days if the patient has additional high-risk features:
- Prolonged immobilization
- Multiple injuries (high Injury Severity Score)
- Cancer
- Prior VTE history 2
Aspirin Management
If the patient is already on aspirin for cardiovascular disease:
- Continue aspirin 75-162 mg daily throughout the fracture treatment period 5, 6
- Aspirin alone provides inadequate VTE prophylaxis in acute trauma but should not be stopped if prescribed for coronary artery disease, prior stroke, or peripheral arterial disease 5, 6
- Add prophylactic-dose LMWH or fondaparinux to the aspirin regimen rather than stopping aspirin 5
If aspirin is being used solely for primary prevention:
- Consider stopping it temporarily and using LMWH/fondaparinux alone for VTE prophylaxis 7
- The combination increases bleeding risk without proven additional benefit in this setting 7
Special Considerations
High Bleeding Risk Scenarios:
- Use mechanical prophylaxis alone (graduated compression stockings and/or intermittent pneumatic compression) until bleeding risk diminishes 2
- Then add pharmacologic prophylaxis once hemostasis is assured 2
If VTE Develops Despite Prophylaxis:
The patient would require therapeutic anticoagulation:
- Apixaban 10 mg twice daily for 7 days, then 5 mg twice daily 8, 3
- Rivaroxaban 15 mg twice daily for 21 days, then 20 mg once daily 7
- Treatment duration: minimum 3 months for provoked VTE 8, 9
Common Pitfall: Do not use apixaban 2.5 mg twice daily as initial prophylaxis - this reduced dose is only for extended secondary prevention after completing at least 6 months of therapeutic anticoagulation for established VTE 9, 3. Using this dose for primary prophylaxis provides inadequate protection.
Monitoring: Assess for signs of VTE (leg swelling, chest pain, dyspnea) and bleeding complications throughout the prophylaxis period. Injury Severity Score and Glasgow Coma Scale correlate with VTE risk 1.